End Cash: The amount of cash held by the company for the given period.
Prima BioMed Ltd (IMMP) had End Cash of $67.59M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$73.66M |
|
$0.05M |
|
$7.01M |
|
$80.66M |
|
$4.27M |
|
$0.59M |
|
$1.04M |
|
$5.31M |
|
$75.35M |
|
$69.66M |
|
$75.35M |
|
118.88M |
|
| Cash Flow Statement Financials | |
$-12.02M |
|
$-0.27M |
|
$-0.28M |
|
$80.42M |
|
|
End Cash |
$67.59M |
$-12.83M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|